About: covid:PMC7313529

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7313529 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Agrawal, Rupesh Agarwal, Manisha Blazes, Marian Bodaghi, Bahram Christoph, Tappeiner De Smet, Marc Gupta, Vishali Kempen, John Lee, Cecilia McCluskey, Peter Nguyen, Quan Okada, Annabelle Pavesio, Carlos Smith, Justine Thorne, Jennifer Testi, Ilaria Tsui, Edmund Zierhut, Manfred
is schema:about of	named entity 'COVID-19 pandemic' named entity 'macrophage inflammatory protein' named entity '31 questions' named entity 'COVID-19' named entity 'IL-6' named entity 'COVID-19' named entity 'corticosteroids' named entity 'viral entry' named entity 'systemic risk' named entity 'COX inhibitors' named entity 'NSAIDs' named entity 'hygiene' named entity 'high-risk' named entity 'high-risk' named entity 'corticosteroid' named entity 'immunosuppression' named entity 'infection' named entity 'inflammatory diseases' named entity 'COVID' named entity 'appendix 1' named entity 'corticosteroid' named entity 'uveitis' named entity 'COVID' named entity 'COVID' named entity 'COVID' named entity 'immunosuppressive agents' named entity 'methylprednisolone' named entity 'intravitreal' named entity 'tocilizumab' named entity 'risk factors' named entity 'methylprednisolone' named entity 'scleritis' named entity 'telehealth' named entity 'personal hygiene' named entity 'COVID-19' named entity 'COVID-19' named entity 'NSAIDS' named entity 'corticosteroids' named entity 'CD200' named entity 'tested positive' named entity 'corticosteroids' named entity 'neutropenia' named entity 'SARS-CoV-2' named entity 'antivirals' named entity 'monoclonal antibody' named entity 'biologics' named entity 'uveitis' named entity 'COVID-19' named entity 'PD1' named entity 'infection status' named entity 'meloxicam' named entity 'COVID-19 pandemic' named entity 'pro-inflammatory' named entity 'tocilizumab' named entity 'cyclophosphamide' named entity 'lung' named entity 'inflammation' named entity 'high-risk' named entity 'April 2020' named entity 'intravenous' named entity 'uveitis' named entity 'COVID-19 pandemic' named entity 'COVID-19 pandemic' named entity 'propionates' named entity 'symptom' named entity 'intravenous' named entity 'corticosteroids' named entity 'COVID' named entity 'methylprednisolone' named entity 'eye disease' named entity 'COVID' named entity 'corticosteroids' named entity 'corticosteroids' named entity 'non-steroidal anti-inflammatory drugs' named entity 'COVID-19 pandemic' named entity 'biologics' named entity 'TNF' named entity 'North America' named entity '31 questions' named entity 'immunosuppressive drug' named entity 'methylprednisolone' named entity 'high-risk'

Attributes

Values

Creator

Agrawal, Rupesh
Agarwal, Manisha
Blazes, Marian
Bodaghi, Bahram
Christoph, Tappeiner
De Smet, Marc
Gupta, Vishali
Kempen, John
Lee, Cecilia
McCluskey, Peter
Nguyen, Quan
Okada, Annabelle
Pavesio, Carlos
Smith, Justine
Thorne, Jennifer
Testi, Ilaria
Tsui, Edmund
Zierhut, Manfred

is schema:about of

named entity 'COVID-19 pandemic'
named entity 'macrophage inflammatory protein'
named entity '31 questions'
named entity 'COVID-19'
named entity 'IL-6'
named entity 'COVID-19'
named entity 'corticosteroids'
named entity 'viral entry'
named entity 'systemic risk'
named entity 'COX inhibitors'
named entity 'NSAIDs'
named entity 'hygiene'
named entity 'high-risk'
named entity 'high-risk'
named entity 'corticosteroid'
named entity 'immunosuppression'
named entity 'infection'
named entity 'inflammatory diseases'
named entity 'COVID'
named entity 'appendix 1'
named entity 'corticosteroid'
named entity 'uveitis'
named entity 'COVID'
named entity 'COVID'
named entity 'COVID'
named entity 'immunosuppressive agents'
named entity 'methylprednisolone'
named entity 'intravitreal'
named entity 'tocilizumab'
named entity 'risk factors'
named entity 'methylprednisolone'
named entity 'scleritis'
named entity 'telehealth'
named entity 'personal hygiene'
named entity 'COVID-19'
named entity 'COVID-19'
named entity 'NSAIDS'
named entity 'corticosteroids'
named entity 'CD200'
named entity 'tested positive'
named entity 'corticosteroids'
named entity 'neutropenia'
named entity 'SARS-CoV-2'
named entity 'antivirals'
named entity 'monoclonal antibody'
named entity 'biologics'
named entity 'uveitis'
named entity 'COVID-19'
named entity 'PD1'
named entity 'infection status'
named entity 'meloxicam'
named entity 'COVID-19 pandemic'
named entity 'pro-inflammatory'
named entity 'tocilizumab'
named entity 'cyclophosphamide'
named entity 'lung'
named entity 'inflammation'
named entity 'high-risk'
named entity 'April 2020'
named entity 'intravenous'
named entity 'uveitis'
named entity 'COVID-19 pandemic'
named entity 'COVID-19 pandemic'
named entity 'propionates'
named entity 'symptom'
named entity 'intravenous'
named entity 'corticosteroids'
named entity 'COVID'
named entity 'methylprednisolone'
named entity 'eye disease'
named entity 'COVID'
named entity 'corticosteroids'
named entity 'corticosteroids'
named entity 'non-steroidal anti-inflammatory drugs'
named entity 'COVID-19 pandemic'
named entity 'biologics'
named entity 'TNF'
named entity 'North America'
named entity '31 questions'
named entity 'immunosuppressive drug'
named entity 'methylprednisolone'
named entity 'high-risk'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software